ArticleThe Journal of clinical investigation2026
Tumor proliferation associates with greater sensitivity to androgen receptor pathway inhibition in metastatic prostate cancer.
Larissa Mendes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.